Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COPE-HCV: Continuous Interferon Delivery Via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV

NCT00919633 is registered in ClinicalTrials.gov with Medtronic Corporate Technologies and New Ventures as lead sponsor.

NCT NCT00919633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00919633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COPE-HCV: Continuous Interferon Delivery Via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV
Lead sponsor
Medtronic Corporate Technologies and New Ventures
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2009
Completion date
July 31, 2012
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c